Andra AP fonden Sells 255,366 Shares of Centene Corporation $CNC

Andra AP fonden lessened its stake in Centene Corporation (NYSE:CNC) by 70.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 104,934 shares of the company’s stock after selling 255,366 shares during the period. Andra AP fonden’s holdings in Centene were worth $3,744,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CNC. Addison Advisors LLC raised its holdings in shares of Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock valued at $26,000 after purchasing an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC purchased a new position in Centene during the third quarter valued at approximately $27,000. WPG Advisers LLC raised its stake in Centene by 44.5% in the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares in the last quarter. Bogart Wealth LLC lifted its holdings in Centene by 11,011.1% during the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock worth $36,000 after buying an additional 991 shares during the period. Finally, Financial Network Wealth Advisors LLC increased its holdings in shares of Centene by 54.9% in the 3rd quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company’s stock valued at $39,000 after acquiring an additional 390 shares during the period. 93.63% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have commented on CNC. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a report on Tuesday, February 10th. Weiss Ratings reissued a “sell (d)” rating on shares of Centene in a research report on Wednesday, January 21st. Argus raised shares of Centene to a “hold” rating in a report on Monday, February 9th. JPMorgan Chase & Co. increased their price objective on Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a report on Thursday, January 22nd. Finally, Wall Street Zen downgraded Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $42.00.

Centene Stock Performance

Shares of NYSE CNC opened at $44.82 on Friday. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.03. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.10 and a current ratio of 1.10. The company’s fifty day moving average price is $42.83 and its 200 day moving average price is $37.56. The company has a market capitalization of $22.04 billion, a PE ratio of -3.29, a price-to-earnings-growth ratio of 1.00 and a beta of 0.48.

Centene (NYSE:CNC) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating analysts’ consensus estimates of ($1.22) by $0.03. Centene had a positive return on equity of 4.25% and a negative net margin of 3.43%.The business had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. During the same period in the previous year, the business earned $0.80 earnings per share. The business’s revenue was up 21.9% compared to the same quarter last year. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. On average, research analysts predict that Centene Corporation will post 6.86 earnings per share for the current year.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.